Melanomas found under the dock of the tail

An equine melanoma is a tumor that results from the abnormal growth of melanocytes in horses. Unlike in humans, melanomas in horses are not thought to be caused by exposure to ultraviolet light.[1] Melanomas are the third most common type of skin cancer in horses, with sarcoids being the first most prevalent and squamous-cell carcinoma being second.[2] Melanomas are typically rounded black nodules that vary in size and are usually found underneath the dock of the tail, in the anal, perianal and genital regions, on the perineum, lips, eyelids, and sometimes near the throatlatch.[3]

These tumors can be either benign, meaning not cancerous, or malignant, meaning cancerous;[4] while the benign tumors typically need little treatment to no treatment, the malignant tumors can cause serious problems and can potentially be life-threatening.[5] Different methods are used to determine if the tumor is malignant and whether it has spread to other organs. Methods used to determine malignancy include fine needle aspirate, biopsy, or complete removal.[4] To determine if the tumor has metastasized, a rectal examination or an ultrasound can be performed; the most frequent location for metastasis include the lymph nodes, spleen, liver, the abdominal wall, the lungs, and blood vessels.[6] If the tumor becomes large enough, it can cause weight loss or colic. It may also affect the horse's ability to turn their head from side to side and eat and drink comfortably if the tumor is on the throat latch area, or cause faecal impaction if tumor is on the anal region.[3] If melanomas become large and ulcerate, they may become infected.[5]

Melanoma in gray horses

Melanomas found on the lip

Gray horses have a higher susceptibility to melanoma than any other coat color, with up to 80% of gray horses developing some kind of melanoma in their lifetime.[4] Some sources state that up to 66% of those melanomas will become malignant.[3] The gray coat color comes from a gene that is responsible for the gradual depigmentation of the horse's coat; horses with this gene are born darker and over time, they lose their coat pigmentation. The gray gene is the strongest coat color modifier, and will act on any base color.[5] The gray coat color is the result of an autosomal dominant trait that is caused by a 4.6-kb duplication in the 6th intron of the gene syntaxin-17 (STX17).[7] The region of this mutation contains four genes: NR4A3 (nuclear receptor subfamily 4, group A, member 3), STX17, TXNDC4 (thioredoxin domain–containing-4¢) and INVS (inversin).[7] To determine what makes gray horses more susceptible to melanomas, researchers have used different techniques such as the Northern Blot technique[8] and Real-Time PCR.[9] From these studies, it was concluded that the STX17 gene and the NR4A3 gene are both being over-expressed in gray horses, which is responsible for the increased incidences of melanoma in horses with the gray gene.[7]

Frequency

One study of gray Quarter horses found that 17.7% had melanomas. The average age of the horses was 9.2 years, and melanomas were much more common in older horses than in younger. When split by age, prevalence was 52% in horse over 15 years old compared to 10% in horses under. This is lower than in other breeds and the authors postulate it may have been because only a few of the horses were homozygous for gray, that the chestnut allele of extension may be protective against melanomas caused by gray, or that the breed's genetic background may lower the risk.[10]

In Lipizzaners, 50% of gray horses had melanotic tumors. Divided by age, 56% of horses under 16 years and 94% of horses older were affected.[11]

Types of melanoma

Not all melanoma tumors are the same; there are four different types of melanomas that can be found in horses.

Melanocytic nevus

This type of tumor is found in younger horses, around 5 years of age, and are usually benign. They can develop on horses of any color as small single masses, less than 2.5 cm (0.98 in), anywhere on the body.[12]

Dermal melanoma

These tumors are usually benign, but can become malignant over time. They vary in size, and can be found as singles or multiples. They are most commonly found in mature grey horses (less than 15 years old), typically under the tail, around the anus, and on the external genitalia.[12]

Dermal melanoatosis

These tumors are frequently malignant and have a high tendency to spread to other organs. They are most commonly found in gray horses over the age of 15 as a large coalescing mass under the tail, around the anus, on the external genitalia, or the parotid salivary gland.[12]

Anaplastic melanoma

These tumors are malignant and frequently spread to other organs. These are rare tumors, typically found in older (more than 20 years of age) non-gray horses.[12]

Treatment

There are several treatment options when a horse is found to have a melanoma tumor.

Surgical removal

The surgical removal of a melanoma tumor is performed when the tumors are small; this prevents the tumors from spreading to the surrounding areas.[13]

Intralesional cisplatin

Cisplatin is a chemotherapy drug that is injected into the tumor itself; this drug is commonly used along with surgical removal. That being said, this drug has been shown to resolve tumors with or without surgical removal for at least 2 years.[14]

Cimetidine

Cimetidine works by slowing tumor growth; it is a histamine blocker that maintains the body's immune response which aids in the killing of tumor cells. Cimetidine has not been proven to efficiently resolve tumors completely.[15]

Melanoma vaccine

A vaccine that is similar to the effective canine melanoma vaccine has been created for equine melanoma,[16] and is being studied at the College of Veterinary Medicine at the University of Florida [4]

References

  1. ↑ "NADIS - National Animal Disease Information Service -". www.nadis.org.uk. Retrieved 2016-11-26.
  2. ↑ Valentine (2006). "Survey of equine cutaneous neoplasia in the Pacific Northwest". J Vet Diagn Invest. 18 (1): 123–126. doi:10.1177/104063870601800121. PMID 16566271. S2CID 34083353.
  3. 1 2 3 Moore, J. S; Shaw, E; Buechner‐Maxwell, V; Scarratt, W. K; Crisman, M; Furr, M; Robertson, J (2013). "Melanoma in horses: Current perspectives". Equine Veterinary Education. 25 (3): 144–151. doi:10.1111/j.2042-3292.2011.00368.x.
  4. 1 2 3 4 Tannler, B (2013). "Equine Melanoma" (PDF). Equine Health Update. 15: 1–2.
  5. 1 2 3 "Gray Coat Color/ Melanoma". www.horsetesting.com. Retrieved 2016-11-26.
  6. ↑ MacGillivray, Katherine Cole; Sweeney, Raymond W.; Piero, Fabio Del (July 2002). "Metastatic melanoma in horses". Journal of Veterinary Internal Medicine. 16 (4): 452–456. doi:10.1111/j.1939-1676.2002.tb01264.x. PMID 12141308.Open access icon
  7. 1 2 3 Pielberg, G.; Golovko, A.; Sundström, E.; Curik, I.; Lennartsson, J.; Seltenhammer, M.; Druml, T.; Binns, M.; Fitzsimmons, C.; Lindgren, G.; Sandberg, K.; Baumung, R.; Vetterlein, M.; Strömberg, S.; Grabherr, M.; Wade, C.; Lindblad-Toh, K.; Pontén, F.; Heldin, C.; Sölkner, J.; Andersson, L. (2008). "A Cis-acting Regulatory Mutation Causes Premature Hair Graying and Susceptibility to Melanoma in the Horse". Nature Genetics. 40 (8): 1004–1009. doi:10.1038/ng.185. PMID 18641652. S2CID 6666394.
  8. ↑ "Northern Blotting". www.lifetechnologies.com. Retrieved 2016-11-26.
  9. ↑ Wang, X., Seed, B. (2003). A PCR primer bank for quantitative gene expression analysis. Nucleic Acids Research, 31(24), e154; 1-8
  10. ↑ Teixeira; Rendahl; Anderson; Mickelson; Sigler; Buchanan (2013). "Coat color genotypes and risk and severity of melanoma in gray quarter horses". Journal of Veterinary Internal Medicine. 27 (5): 1201–1208. doi:10.1111/jvim.12133. PMID 23875712.
  11. ↑ Fleury, Catherine; Bérard, Frederic; Balme, Brigitte; Thomas, Luc (2000). "The Study of Cutaneous Melanomas in Camargue‐Type Gray‐Skinned Horses (1): Clinical–Pathological Characterization". Pigment Cell & Melanoma Research. 13 (1): 39–46. doi:10.1034/j.1600-0749.2000.130108.x. PMID 10761995.
  12. 1 2 3 4 Valentine, Beth A. (September 1995). "Equine melanocytic tumors: a retrospective study of 53 horses (1988 to 1991)". Journal of Veterinary Internal Medicine. 9 (5): 291–297. doi:10.1111/j.1939-1676.1995.tb01087.x. PMID 8531173.Open access icon
  13. ↑ Rowe, E.L.; Sullins, K.E. (2004). "Excision as treatment of dermal melanomatosis in horses: 11 cases (1994-2000)". Journal of the American Veterinary Medical Association. 225 (1): 94–96. doi:10.2460/javma.2004.225.94. PMID 15239480.
  14. ↑ Hewes, C.A.; Sullins, K.E. (2006). "Use of cisplatin-containing biodegradable beads for treatment of cutaneous neoplasia in Equidae: 59 cases (2000-2004)". Journal of the American Veterinary Medical Association. 229 (10): 1617–1622. doi:10.2460/javma.229.10.1617. PMID 17107319.
  15. ↑ Goetz, T. E.; Ogilvie, G. K.; Keegan, K. G.; Johnson, P. J. (1990). "Cimetidine for treatment of melanomas in three horses". J Am Vet Med Assoc. 196 (3): 449–52. PMID 2298676.
  16. ↑ Bergman, P.J.; Camps-Palau, M.A.; Mcknight, J.A.; Leibman, N.F.; Craft, D.M.; Leung, C.; Liao, J.; Riviere, I.; Sadelain, M.; Hohenhaus, A.E.; Gregor, P.; Houghton, A.N.; Perales, M.A.; Wolchok, J.D. (2006). "Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center". Vaccine. 24 (21): 4582–4585. doi:10.1016/j.vaccine.2005.08.027. PMID 16188351.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.